Literature DB >> 7930745

National surveillance for respiratory syncytial virus, United States, 1985-1990.

S Gilchrist1, T J Török, H E Gary, J P Alexander, L J Anderson.   

Abstract

Respiratory syncytial virus (RSV) causes pneumonia and bronchiolitis in infants and young children and serious disease in the elderly and persons with compromised immune systems. To determine the temporal and geographic patterns of RSV outbreaks in the United States, monthly reports from 74 laboratories were analyzed for July 1985 through June 1990. RSV outbreaks were identified in 197 (93%) of the 211 laboratory years analyzed, with widespread activity beginning each fall, peaking in winter, and returning to baseline in April or May. Each year, the timing of outbreaks did not differ significantly between most regions; the few differences were small, and no region consistently had early or late outbreaks. These findings are consistent with RSV transmission within communities rather than between communities or regions. Health care personnel should consider the possibility of RSV infection in their treatment and prevention efforts from November through April each year in the United States.

Entities:  

Mesh:

Year:  1994        PMID: 7930745     DOI: 10.1093/infdis/170.4.986

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections.

Authors:  Yange Zhang; W Abdullah Brooks; Doli Goswami; Mustafizur Rahman; Stephen P Luby; Dean D Erdman
Journal:  J Virol Methods       Date:  2014-05-23       Impact factor: 2.014

Review 2.  The role of the respiratory syncytial virus in airway syndromes in childhood.

Authors:  Mark L Everard
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

3.  Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus.

Authors:  Les P Jones; Hao-Qiang Zheng; Ruth A Karron; Teresa C T Peret; Cecelia Tsou; Larry J Anderson
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations.

Authors:  Gabriel J Escobar; Tebeb Gebretsadik; Kecia Carroll; Sherian Xu Li; Eileen M Walsh; Pingsheng Wu; Ed Mitchel; Chantel Sloan; Tina Hartert
Journal:  J Pediatric Infect Dis Soc       Date:  2013-03-21       Impact factor: 3.164

5.  Respiratory syncytial virus and neutrophil activation.

Authors:  E L Bataki; G S Evans; M L Everard
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

6.  Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.

Authors:  S S Whitehead; M G Hill; C Y Firestone; M St Claire; W R Elkins; B R Murphy; P L Collins
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.

Authors:  S S Whitehead; A Bukreyev; M N Teng; C Y Firestone; M St Claire; W R Elkins; P L Collins; B R Murphy
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.

Authors:  H Nguyen; J Hay; T Mazzulli; S Gallinger; J Sandhu; Y Teng; N Hozumi
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

9.  Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus.

Authors:  A Jones; I Morton; L Hobson; G S Evans; M L Everard
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

10.  Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide.

Authors:  L Hobson; M L Everard
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.